Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills
  1. Research Outputs

Medical Treatment of Myomas

Chapter
Publication Date:
2016
Short description:
Medical Treatment of Myomas / Genazzani, A.D., Chierchia, E., Despini, G., Prati, A. (ISGE SERIES). - In: Frontiers in Gynecological Endocrinology[s.l] : Springer Nature, 2016. - pp. 141-149 [10.1007/978-3-319-23865-4_17]
abstract:
Uterine fibroids or myomas are the most frequent benign neoplasm during fertile life in women. It originates from the smooth muscle cells of the uterus (myometrium) [1], and it is frequently found at a gynecological examination or at ultrasound in almost 30 % of the women above 35 years of age. Myomas are usually asymptomatic, but in 30 % of the women, they can induce a variety of symptoms such as dysmenorrhea, menorrhagia, pelvic discomfort, infertility, recurrent abortion, and when there several myomas and/or when they are quite large and heavy, they can induce diseases for the compression of the tissues and/or organs close to the uterus, such as the bladder [2].
Iris type:
Capitolo/Saggio
Keywords:
Aromatase Inhibitor; Climacteric Symptom; GnRH Analogue; Heavy Menstrual Bleeding; Uterine Fibroid
List of contributors:
Genazzani, A. D.; Chierchia, E.; Despini, G.; Prati, A.
Authors of the University:
GENAZZANI Alessandro
Handle:
https://iris.unimore.it/handle/11380/1288137
Book title:
Frontiers in Gynecological Endocrinology
Published in:
ISGE SERIES
Series
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.6.0.0